Research Paper Volume 16, Issue 13 pp 10813—10831
An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer
Figure 7. WDHD1-related immune responses in immunotherapy. (A) Heatmap of the correlation between WDHD1 and immune checkpoints. (B) Heatmap of correlation between WDHD1 and TMB from TCGA database. (C) Histograms of WDHD1-associated ICB treatment efficacy between WDHD1 high-expression and low-expression groups were obtained from the TCGA database by the TIDE algorithm. Low scores indicate good efficacy.